USC Norris Comprehensive Cancer Center Opens Newport Beach Radiation Oncology and Imaging Center
Keck Medicine of USC - Newport Beach Radiation Oncology and Imaging will be the first Orange County facility to offer innovative biology-guided radiation therapy, which interacts with cancer cells to send up-to-the-minute 'signals' identifying where cancer cells are in the body
USC Norris Comprehensive Cancer Center, part of Keck Medicine of USC, has opened Keck Medicine of USC - Newport Beach Radiation Oncology and Imaging, a state-of-the-art radiation oncology and imaging center, at 4590 MacArthur Blvd. in Newport Beach. The 12,500-square-foot clinical space houses new-to-market imaging and radiation therapy technology in a serene, beach-inspired space designed to help patients feel at ease.
'Our new radiation oncology and imaging center demonstrates our ongoing commitment to providing Orange County with world-class care,' said Rod Hanners, CEO of Keck Medicine. 'We recognize the importance of keeping cancer care close to home and are proud to expand our presence in the community.' The center is equipped with positron emission tomography-computed tomography (PET-CT) imaging and computed tomography (CT) scanners for diagnosis, treatment simulation and monitoring, as well as two state-of-the-art linear accelerators to deliver precision radiation therapy treatment.
Keck Medicine of USC - Newport Beach Radiation Oncology and Imaging will be the first clinical site in Orange County, and just the third in California, to offer SCINTIX biology-guided radiation therapy (BgRT) using the new-to-market RefleXion X1 system.
Unlike other types of radiation therapy that use static images of a patient's anatomy to map treatment areas, BgRT is the first and only radiation therapy delivery modality that uses a PET radiotracer compound that, once injected into the body, interacts with cancer cells to send up-to-the-minute 'signals' about the location of cancer cells, even as the patient breathes or moves slightly. This helps radiation oncologists track, target and treat cancer cells in real time while minimizing damage to healthy cells, which may alleviate some of the side effects of radiation.
BgRT also eliminates the need for placing markers (tiny metal objects positioned inside the patient in or near cancerous tissue to identify where to deliver treatment), as well as enables radiation oncologists to more efficiently treat multiple tumor locations in the same course of therapy.
BgRT recently received breakthrough device designation from the U.S. Food and Drug Administration for treating lung tumors and is currently approved for certain patients with lung and bone tumors.
Keck Medicine will install a second X1 system with BgRT at a medical facility in Pasadena opening later this year. It will be the first university-based academic institution to offer BgRT at multiple locations, bringing new cancer treatment options to the Los Angeles area, Orange County and surrounding communities.
'This groundbreaking technology enables us to provide the best possible care and offer treatment for patients whose options may be very limited,' said May Lin Tao, MD, radiation oncologist and director of clinical operations, regional radiation oncology clinics, with Keck Medicine. Tao is also clinical associate professor of radiation oncology with the Keck School of Medicine of USC. 'We are thrilled to be the first to offer this revolutionary and potentially life-saving treatment to patients in Orange County.'
Keck Medicine of USC - Newport Beach Radiation Oncology and Imaging is less than 15 minutes away from USC Norris' oncology locations in Newport Beach and Irvine, where patients can make appointments with respected medical oncologists who have served Orange County for decades and who treat more medical oncology outpatients in Newport Beach than any other provider.
'This new location expands our spectrum of cancer services in Orange County, ranging from diagnostic imaging to multiple treatment options that optimize outcomes and provide personalized radiation medicine,' said Eric Chang, MD, radiation oncologist with Keck Medicine and chair and professor of radiation oncology with the Keck School.
'The addition of this new location means so much for our patients and their loved ones,' said Louis Vandermolen, MD, medical oncologist with USC Norris Comprehensive Cancer Center, practicing in Newport Beach. 'Our convenient location near our medical oncology offices means that our patients can truly benefit from multidisciplinary, collaborative care from doctors they know and trust.'
Information sourced from Keck Medicine of USC. To learn more, contact mary.ferguson@med.usc.edu.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
Chronic Absenteeism Hasn't Gone Away After Lockdowns. Research Shows Poor Kids Are Hurt Most.
Chronic absenteeism has long been cited as one of the most severe lasting impacts of COVID-era school shutdowns. New research indicates that the problem is sticking around for groups of students already facing significant disadvantages. "The income gap really was the main driver that showed up over and over again," said University of Southern California (USC) education professor Morgan Polikoff during a presentation of his research at an American Enterprise Institute (AEI) event last week. "The fact that student-level income is the main driver here seems to be really important." Chronic absenteeism—often defined as when a student is absent for more than 10 percent of the school year—skyrocketed during the pandemic. According to AEI's absenteeism tracker, by 2022, national chronic absenteeism increased by 89 percent when compared to three years prior. While absenteeism has declined from its 2022 peak in most states that report such data, 2024 figures show it remains higher than pre-pandemic levels. Absolute rates of absenteeism varied broadly state by state. In Alabama, students had the lowest rate, peaking at 18 percent in 2022 and falling to 15 percent in 2024. By contrast, nearly half of all students in Washington, D.C., were chronically absent in 2022, dropping to a still-staggering 40 percent in 2024. According to Polikoff's research, low-income students in particular are facing persistent increases in absenteeism when compared to pre-pandemic numbers. Polikoff looked at school absenteeism data from North Carolina and Virginia. He explained that, when comparing absenteeism from before and after the pandemic, the attendance gap between low-income and non-low-income students grew dramatically. Post-pandemic, Virginia low-income students were 12.1 percentage points more likely to be chronically absent than other students, and in North Carolina, these students were 14.4 percentage points more likely to be chronically absent. Polikoff noted that the gap between different racial groups was relatively minor after controlling for income. "When looking in absolute terms, the most disadvantaged groups are typically more likely to have seen larger increases in chronic absenteeism," he said. "Racial gaps are not overly large, controlling for income and other things. How exactly to reverse these trends has long puzzled education professionals. School districts have tried everything from home visits to free ice cream and gift cards, yet the problem remains persistent. "[Absenteeism is] what the corona did," a 21-year-old told ProPublica reporter Alec MacGillis in a story co-published with The New Yorker last year. "They're sending the kids back to school, and they don't want to no more. They want to stay home and play on their computers." The post Chronic Absenteeism Hasn't Gone Away After Lockdowns. Research Shows Poor Kids Are Hurt Most. appeared first on
Los Angeles Times
2 days ago
- Los Angeles Times
USC and UCLA Team Up for World's First-in-Human Bladder Transplant
Historic surgery, the result of years of research at Keck Medicine of USC and UCLA Health, opens the door for improved treatment of non-functioning bladders Surgeons from Keck Medicine of USC and UCLA Health have performed the world's first-in-human bladder transplant. The surgery was successfully completed at Ronald Reagan UCLA Medical Center earlier this month in a joint effort by Inderbir Gill, MD, founding executive director of USC Urology, and Nima Nassiri, MD, urologic transplant surgeon and director of the UCLA Vascularized Composite Bladder Allograft Transplant Program. 'This surgery is a historic moment in medicine and stands to impact how we manage carefully selected patients with highly symptomatic 'terminal' bladders that are no longer functioning,' said Gill, who is also chair and Distinguished Professor of Urology and Shirley and Donald Skinner Chair in Urologic Cancer Surgery with the Keck School of Medicine of USC. 'Transplantation is a life-saving and life-enhancing treatment option for many conditions affecting major organs, and now the bladder can be added to the list.' 'This first attempt at bladder transplantation has been over four years in the making,' Nassiri said. 'For the appropriately selected patient, it is exciting to be able to offer a new potential option.' Nassiri, formerly a urology resident with the Keck School and now assistant professor of urology and kidney transplantation at UCLA, and Gill worked together for several years at the Keck School to develop the new surgical technique, design a clinical trial and secure the necessary regulatory approvals. Numerous pre-clinical procedures were performed both at Keck Medical Center of USC and OneLegacy, Southern California's organ procurement organization, to prepare for this first-in-human bladder transplant. The patient had been dialysis-dependent for seven years. He lost the majority of his bladder during surgery to resect cancer over five years ago, leaving the remainder of his bladder too small and compromised to function appropriately. Both of his kidneys were subsequently removed due to renal cancer. To address these deficits, Drs. Gill and Nassiri performed a combined kidney and bladder transplant, allowing the patient to immediately stop dialysis and produce urine for the first time in seven years. First, the kidney and then the bladder were transplanted. The new kidney was then connected to the new bladder. The entire procedure took approximately eight hours. 'The kidney immediately made a large volume of urine, and the patient's kidney function improved immediately,' Nassiri added. 'There was no need for any dialysis after surgery, and the urine drained properly into the new bladder.' 'Despite the complexity of the case, everything went according to plan and the surgery was successful,' said Gill. 'The patient is doing well, and we are satisfied with his clinical progress to date.' The recovery of the kidney and bladder from the donor was performed at OneLegacy's Transplant Recovery Center in Azusa, California. All parts of the procedure, including surgery and post-surgical monitoring during the transplantation, were aligned with the highest current clinical and research standards. Millions of people around the globe experience some degree of bladder disease and dysfunction. Some develop terminal bladders that are either non-functioning and/or cause constant pain, repeated infections and other complications. Current treatment for severe terminal cases of bladder dysfunction or a bladder that has been removed due to various conditions includes replacement or augmentation of the urinary reservoir. These surgeries use a portion of a patient's intestine to create a new bladder or a pathway for the urine to exit the body. 'While these surgeries can be effective, they come with many short- and long-term risks that compromise a patient's health, such as recurrent infections, compromised kidney function and digestive issues,' said Gill. 'A bladder transplant, on the other hand, delivers a more 'normal' urinary reservoir and may circumvent some of the challenges associated with using the intestine,' said Nassiri. The biggest risks of organ transplant are the body's potential rejection of the organ and side effects caused by the mandatory immunosuppressive drugs given to prevent organ rejection. 'Because of the need for long-term immunosuppression, the best current candidates are those with a pre-existing organ transplant or those who need a combined kidney and bladder transplant,' said Nassiri. As a first-in-human attempt, there are naturally many unknowns associated with the procedure, such as how well the transplanted bladder will function immediately and over time, and how much immunosuppression will ultimately be needed. 'Despite the unknowns, our goal is to understand if bladder transplantation can help patients with severely compromised bladders lead healthier lives,' said Gill. Bladder transplants have not been done previously, in part because of the complicated vascular structure of the pelvic area and the technical complexity of the procedure. As part of the research and development stage, Gill and Nassiri successfully completed numerous practice transplantation surgeries at Keck Medical Center of USC, including the first-ever robotic bladder retrievals and successful robotic transplantations in five recently deceased donors with cardiac function maintained on ventilator support. Several non-robotic trial runs of bladder recovery were performed at OneLegacy by Gill and Nassiri, allowing them to perfect the technique while working alongside multidisciplinary surgical teams. The bladder transplant was done as part of a UCLA clinical trial. Gill and Nassiri hope to perform more bladder transplants together in the near future. Under Gill's leadership, USC Urology has rapidly established itself as a pioneer and world leader in the most advanced robotic urologic oncologic surgeries for kidney, bladder, prostate, testicular and penile cancers and has achieved important milestones leveraging machine learning and artificial intelligence to optimize patient outcomes. Information was sourced from Keck Medicine of USC. To learn more, contact
NBC Sports
2 days ago
- NBC Sports
Paralympic venue plan outlined for 2028 Los Angeles Games
The 2028 Los Angeles Paralympic venue map has taken shape with a plan for all of the competition sites to be within a 35-miles radius. After the Opening Ceremony at SoFi Stadium on Aug. 15, 2028, medal events will be held at LA venues including the Coliseum (track and field), Arena (wheelchair basketball) and USC's Galen Center (badminton and wheelchair rugby). Competition will also be held in Long Beach, Carson and Arcadia. The Coliseum will also host the Closing Ceremony on Aug. 27. 'The Paralympic Games showcases the highest level of athleticism, skill and endurance, and it is important for LA28 to deliver a plan that not only elevates Paralympic sport, but brings it to the next level,' LA 2028 CEO Reynold Hoover said in a press release. 'The Paralympic venue plan ensures that Los Angeles' first-ever Paralympic Games will take place in incredible existing stadiums and arenas across the region while creating the best possible experience for athletes and fans across the 560 events with accessibility top of mind.' The Paralympic village where athletes stay will be on UCLA's campus. The venue for powerlifting, the start and finish location and course for road cycling and the course and finish location for the marathon will be announced at a later date. 'The first-ever Paralympic Games in Los Angeles will showcase the world's top talent and provide an opportunity for L.A. to improve inclusive accessibility citywide,' LA mayor Karen Bass said in the release. 'The legacy of these Games will be imprinted on our city forever – proliferating beyond the boundaries of these venues to better all of Los Angeles.' 2028 Los Angeles Paralympic Venues Los Angeles – 2028 Host City • Boccia in the Convention Center in Downtown Los Angeles • Goalball in Peacock Theater in Downtown Los Angeles • Para Athletics at the LA Memorial Coliseum • Para Badminton in the USC Sports Center • Para Judo in the Convention Center in Downtown Los Angeles • Para Marathon in Venice Beach (starting point) • Para Table Tennis in the Convention Center in Downtown Los Angeles • Para Taekwondo in the Convention Center in Downtown Los Angeles • Para Triathlon in Venice Beach • Wheelchair Basketball in the Arena in Downtown Los Angeles • Wheelchair Fencing in the Convention Center in Downtown Los Angeles • Wheelchair Rugby in the USC Sports Center Long Beach – 2028 Venue City • Blind Football at Alamitos Beach in Long Beach • Para Canoe – Sprint at Marine Stadium in Long Beach • Para Climbing at the Convention Center Lot in Long Beach • Para Rowing at Marine Stadium in Long Beach • Para Swimming at the Convention Center Lot in Long Beach • Shooting Para Sport in the Convention Center in Long Beach • Sitting Volleyball in the Arena in Long Beach Carson – 2028 Venue City • Para Archery at the Fields in Carson • Wheelchair Tennis at the Tennis Center in Carson • Para Cycling - Track at Velodrome in Carson Arcadia • Para Equestrian at Santa Anita Park in Arcadia 2028 Los Angeles Paralympic Venue Renderings Track and field at the Los Angeles Memorial Coliseum. (all renderings via LA 2028) Wheelchair basketball at Arena. Multiple sports in Long Beach. Wheelchair tennis in Carson. Wheelchair rugby at USC's Galen Center. Badminton at USC's Galen Center. Judo at the LA Convention Center. Nick Zaccardi,
